This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of other and unspecified major salivary glands
C3_SALIVARYNAS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
129 |
4. Check minimum number of eventsNone |
129 |
5. Include endpointsNone |
129 |
6. Filter based on genotype QC (FinnGen only) |
125 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified major salivary glands
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and unspecified major salivary glands, including Hilmo
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, including Hilmo
- Solid cancers
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 125 | 58 | 67 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 66.17 | 66.09 | 66.24 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 129
- Matched controls
- 1290
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EP1AE
NOMESCO Finland
Neck ultrasound examination
42.9
72.5
47
17
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
29.8
60.0
44
22
ELB30
NOMESCO Finland
Excision of submandibular gland
874.9
58.5
53
*
XX3DW
NOMESCO Finland
Time consuming IT work
26.2
56.8
44
25
WZC00
NOMESCO Finland
Treatment plan or consultation
14.9
51.2
96
211
C08.09
ICD-10 Finland
Malignant tumor of the submandibular or submaxillary gland, other or unspecified histology
+∞
49.1
44
*
130
Kela drug reimbursment
Malignant tumour
+∞
45.5
41
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
45.5
41
*
D11.70
ICD-10 Finland
Gland sublingual
480.5
36.9
35
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
29.3
27
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
29.3
27
*
H02AB02
ATC
dexamethasone; systemic
123.6
28.0
29
*
C08.02
ICD-10 Finland
Cystic adenocarcinoma of the submandibular or submaxillary glands
+∞
27.0
25
*
8200/3-C08.0
ICD-O-3
Adenoid cystic carcinoma of submandibular gland
+∞
24.8
23
*
Z51.5
ICD-10 Finland
Palliative care
21.7
22.5
33
20
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
262.7
22.3
22
*
N02AA05
ATC
oxycodone; systemic
6.4
21.5
47
106
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
21.4
20
*
A03FA01
ATC
metoclopramide; systemic, rectal
6.5
20.7
43
92
A04AA02
ATC
granisetron; systemic, transdermal
+∞
20.3
19
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
124.3
20.2
21
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
19.2
18
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
19.2
18
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
19.2
18
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
26.7
19.1
26
12
C08.00
ICD-10 Finland
Malignant tumor of submandibular or submaxillary gland, not histology
+∞
18.1
17
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
18.1
17
*
WF002
NOMESCO Finland
Radical radiotherapy
73.6
17.3
19
*
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
103.8
17.0
18
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
22.3
16.8
24
13
SAA03
NOMESCO Finland
Extended examination of mouth
4.6
16.4
77
316
JN4AD
NOMESCO Finland
Body CT examination
8.2
16.3
24
35
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
16.0
15
*
C08.0
ICD-10 Finland
Malignant neoplasm: Submandibular gland
+∞
16.0
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
14.9
14
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
168.3
14.8
15
*
JN6AD
NOMESCO Finland
CT of torso and neck
48.5
14.5
17
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
4.1
14.1
77
342
C08.90
ICD-10 Finland
Malignant tumor in unspecified large salivary gland without histology
+∞
13.8
13
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
13.8
13
*
L03AA13
ATC
pegfilgrastim; parenteral
155.7
13.7
14
*
WZC30
NOMESCO Finland
Teaching
5.0
13.5
35
89
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
56.1
13.1
15
*
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
22.9
12.9
18
9
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
12.7
12
*
C08.01
ICD-10 Finland
Diverse adenocarcinoma of the mandibular salivary gland
+∞
12.7
12
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
12.7
12
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.7
12
*
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
143.4
12.7
13
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
18.3
12.6
19
12
A07AA02
ATC
nystatin; oral
7.0
12.6
21
35
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.4
11.8
36
104
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
11.6
11
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
11.6
11
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
11.6
11
*
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
11.6
11
*
L02BB03
ATC
bicalutamide; oral
+∞
11.6
11
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
131.2
11.6
12
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
38.9
11.5
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
11.4
48
174
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
65.6
10.8
12
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
119.3
10.6
11
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.6
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.6
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.6
10
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
+∞
10.6
10
*
L03AA02
ATC
filgrastim; parenteral
+∞
10.6
10
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
10.6
10
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
35.8
10.5
13
*
EBA10
NOMESCO Finland
Operative extraction of tooth
5.0
10.4
25
59
JN4BD
NOMESCO Finland
Extensive body CT
8.3
10.0
22
31
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
59.6
9.8
11
*
XW000
NOMESCO Finland
Bone marrow biopsy
13.8
9.7
16
13
C08.9
ICD-10 Finland
Malignant neoplasm: Major salivary gland, unspecified
+∞
9.5
9
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
9.5
9
*
R4190
NOMESCO Finland
Nutritional therapy
15.2
9.4
15
11
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
26.2
9.1
12
5
C08.91
ICD-10 Finland
Adenocarcinoma of mixed cell type in unspecified large salivary gland
+∞
8.4
8
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
8430/3-C08.0
ICD-O-3
Mucoepidermoid carcinoma of submandibular gland
+∞
8.4
8
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
+∞
8.4
8
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
35.8
8.2
10
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
47.9
7.8
9
*
A04AA01
ATC
ondansetron; systemic, rectal
11.1
7.7
14
14
WX402
NOMESCO Finland
General anaesthesia
3.2
7.5
36
138
115
Kela drug reimbursment
Breast cancer
+∞
7.4
7
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.4
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.4
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.4
7
*
8200/3-C08.9
ICD-O-3
Adenoid cystic carcinoma of major salivary gland, NOS
+∞
7.4
7
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
7.4
7
*
EJB30
NOMESCO Finland
Excision of tumor or other lesion of floor of the mouth
+∞
7.4
7
*
C08.94
ICD-10 Finland
Mucoepidermoid carcinoma of an unspecified large salivary gland
+∞
7.4
7
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
17.9
6.9
10
6
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
42.3
6.8
8
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
42.3
6.8
8
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
6.6
6.6
16
27
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
15.3
6.5
10
7
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
73.3
6.5
7
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.4
6.4
17
43
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
6.3
6
*
SPF20
NOMESCO Finland
Temporary relining of dentures
+∞
6.3
6
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
6.3
6
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
6.3
6
*
C08.89
ICD-10 Finland
Malignant overall tumor the large salivary glands anna or unspecified histology
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
8140/3-C08.0
ICD-O-3
Adenocarcinoma, NOS, of submandibular gland
+∞
6.3
6
*
C08.19
ICD-10 Finland
Malignant tumor of the sublingual gland, other or unspecified histology
+∞
6.3
6
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
6.3
6
*
K11.70
ICD-10 Finland
Hypoptyalism
+∞
6.3
6
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
6.3
6
*
C08.99
ICD-10 Finland
Malignant tumor of unspecified large salivary gland, other or unspecified histology
+∞
6.3
6
*
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.7
6.3
44
207
SAA04
NOMESCO Finland
Special examination of mouth
6.6
6.2
15
25
SCA02
NOMESCO Finland
Preventive oral health care
4.2
6.0
17
45
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
36
14
35.06
28.08
1.5
1.2
—
—
—
0
0
67
342
3.00
8.64
3.6
2.0
2.38
2.36
mmol/l
0.88
61
294
77
448
2.78
7.43
2.8
2.4
—
—
estimate
—
0
0
29
123
2.75
4.93
10.2
6.3
—
—
—
0
0
22
84
2.95
4.51
2.9
2.0
75.73
60.22
ml/min/173m2
1.24
11
27
11
21
5.62
4.25
1.4
1.0
—
—
—
0
0
9
13
7.35
4.24
1.3
1.1
—
—
—
0
0
71
473
2.11
4.19
6.6
5.8
1.21
1.21
mmol/l
0.21
63
436
42
229
2.24
4.13
2.5
2.1
—
—
—
0
0
102
796
2.34
3.85
13.9
5.5
79.86
78.35
u/l
0.10
95
743
10
22
4.83
3.51
1.1
1.1
—
—
—
0
0
32
167
2.22
3.44
2.2
1.7
—
—
—
0
0
27
131
2.34
3.44
1.4
1.6
—
—
—
0
0
74
532
1.92
3.23
8.5
6.2
1.22
1.21
mmol/l
0.19
61
463
6
8
7.79
3.09
1.2
1.0
—
—
—
0
0
5
5
10.33
3.00
2.4
3.0
—
—
—
0
0
5
5
10.33
3.00
2.4
2.4
15.60
11.20
%
—
5
5
98
799
1.94
2.65
4.7
4.6
12.37
11.98
mm/h
0.11
87
733
6
11
5.66
2.57
1.0
1.1
—
—
—
0
0
83
653
1.76
2.40
6.3
4.7
7.03
6.79
mmol/l
0.53
78
617
5
8
6.44
2.39
1.0
1.1
—
—
—
0
0
5
8
6.44
2.39
1.0
1.1
—
—
—
0
0
5
8
6.44
2.39
1.0
1.1
—
—
—
0
0
5
9
5.73
2.23
1.2
1.1
—
—
—
0
0
14
62
2.41
2.16
1.1
1.4
—
—
—
0
0
23
126
2.00
2.16
1.6
1.7
—
—
—
0
0
7
20
3.64
2.08
1.0
1.3
—
—
—
0
0
8
27
3.09
1.97
1.1
1.0
—
—
—
0
0
5
11
4.68
1.96
1.0
1.1
—
—
—
0
0
13
62
2.22
1.72
1.3
1.6
—
—
—
0
0
6
19
3.26
1.68
1.7
1.3
—
—
—
0
0
6
20
3.09
1.60
1.2
1.1
—
—
—
0
0
8
33
2.52
1.56
1.6
1.6
19.11
42.95
u/ml
—
8
33
120
1111
2.15
1.55
16.6
10.4
24.85
25.42
u/l
0.18
113
1064
6
21
2.94
1.52
1.0
1.9
—
—
—
0
0
20
118
1.82
1.52
3.9
3.2
—
—
—
0
0
115
1045
1.93
1.51
25.4
13.7
33.30
23.45
mg/l
1.85
100
833
9
38
2.47
1.49
1.6
3.3
—
—
—
0
0
60
476
1.49
1.40
1.9
2.5
77.83
79.10
nmol/l
0.14
54
419
6
23
2.68
1.38
1.2
1.0
—
—
—
0
0
6
24
2.57
1.32
1.2
1.0
—
—
—
0
0
42
317
1.48
1.22
5.7
3.7
0.00
0.00
estimate
-0.00
16
111
11
193
0.53
1.20
1.5
1.3
14.64
8.03
u/ml
—
5
74
49
385
1.44
1.16
4.0
3.2
—
—
—
0
0
7
32
2.25
1.10
2.0
1.6
—
—
—
0
0
14
83
1.77
1.06
1.9
1.4
66.29
66.76
g/l
0.09
14
76
18
116
1.64
1.03
1.2
1.5
—
—
—
0
0
49
394
1.39
1.00
2.9
3.1
967.84
1203.17
ng/l
0.29
43
333
16
237
0.63
0.93
1.3
1.3
0.35
1.05
u/ml
—
6
60
6
28
2.20
0.93
2.2
1.5
—
—
—
0
0
91
816
1.39
0.91
4.3
4.3
14.81
14.99
pmol/l
0.28
79
733
6
29
2.12
0.90
1.2
1.2
—
—
—
0
0
14
207
0.64
0.81
1.2
1.3
33.80
31.05
iu/ml
—
5
62
56
479
1.30
0.72
5.4
3.7
68.04
42.01
ng/l
0.36
49
357
24
182
1.39
0.68
3.1
1.7
30.58
29.78
s
0.19
24
177
78
703
1.28
0.64
3.5
3.2
70.15
46.89
u/l
0.72
71
662
50
429
1.27
0.61
4.7
3.7
0.00
0.00
estimate
-0.00
14
95
105
987
1.34
0.60
5.2
5.4
2.07
1.91
mu/l
0.66
93
891
0
23
0.00
0.59
0.0
1.0
—
1.46
—
0
14
0
23
0.00
0.59
0.0
1.3
—
—
—
0
0
6
36
1.70
0.57
1.8
1.9
—
—
—
0
0
18
136
1.38
0.52
5.8
5.3
29.64
32.88
%
0.64
11
77
109
1036
1.34
0.52
24.6
13.6
76.05
77.16
ml/min/173m2
0.25
103
951
43
495
0.80
0.52
1.7
2.1
1.37
1.33
mmol/l
0.16
34
401
7
109
0.62
0.51
2.0
2.1
28.43
27.57
u/l
—
7
88
37
316
1.24
0.46
3.9
3.1
0.21
0.34
e6/l
0.80
30
229
110
1054
1.30
0.42
5.3
5.4
6.11
6.03
mmol/l
0.27
96
957
0
15
0.00
0.41
0.0
5.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
558.82
—
0
11
0
16
0.00
0.41
0.0
1.1
—
43.71
—
0
10
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
7.41
—
0
12
5
35
1.45
0.40
1.4
1.2
—
—
—
0
0
23
190
1.26
0.38
2.5
3.1
1.21
1.09
e6/l
0.11
16
98
63
581
1.16
0.33
5.0
3.8
0.00
0.00
estimate
-0.00
17
119
28
242
1.20
0.31
2.6
2.9
0.59
0.77
ug/l
1.25
21
146
12
93
1.32
0.31
1.3
1.3
—
—
—
0
0
8
66
1.23
0.27
1.9
1.4
—
—
—
0
0
62
579
1.14
0.26
4.8
3.8
0.00
0.00
estimate
-0.00
17
118
15
124
1.24
0.25
2.6
3.0
5.90
5.72
kpa
0.21
15
119
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
60.23
—
0
10
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
1318.85
—
0
13
26
234
1.14
0.18
2.0
1.8
544.30
459.65
pmol/l
0.47
20
189
37
342
1.11
0.17
3.0
3.8
18.54
24.51
%
2.39
20
156
62
590
1.10
0.17
5.0
3.7
0.00
0.00
estimate
-0.00
17
107
8
71
1.14
0.16
16.8
9.6
24.29
24.84
mmol/l
—
8
71
6
80
0.74
0.16
1.5
1.7
—
—
—
0
0
33
356
0.90
0.16
1.8
1.6
24.88
21.04
nmol/l
0.53
22
296
10
85
1.19
0.13
1.8
2.6
0.18
0.21
e6/l
—
10
79
26
240
1.10
0.12
2.5
1.7
1.65
1.30
mg/l
0.21
21
189
16
144
1.13
0.11
1.4
1.5
—
—
—
0
0
27
252
1.09
0.10
5.8
4.0
1.02
1.02
kg/l
0.45
15
164
5
46
1.09
0.09
1.2
1.3
—
—
—
0
0
6
55
1.10
0.09
1.0
1.1
—
—
—
0
0
100
1012
0.95
0.05
4.1
4.7
1.26
1.28
mmol/l
0.11
87
912
105
1040
1.05
0.03
6.7
7.0
40.94
39.94
mmol/mol
0.48
91
968
56
551
1.03
0.02
1.9
2.1
91.10
95.86
pmol/l
0.20
22
270
109
1082
1.05
0.02
5.4
6.5
2.63
2.62
mmol/l
0.01
96
989
107
1066
1.02
0.00
4.6
5.6
4.57
4.52
mmol/l
0.20
93
976
106
1059
1.01
0.00
4.7
5.5
1.47
1.44
mmol/l
0.26
93
965
43
432
0.99
0.00
4.5
4.3
1.93
2.00
ug/l
0.08
35
376
10
97
1.03
0.00
2.0
1.8
432.60
381.29
nmol/l
—
10
90
46
455
1.02
0.00
4.3
4.1
6.54
7.85
mg/mmol
0.16
30
274
57
575
0.98
0.00
2.9
2.6
—
—
—
0
0
20
205
0.97
0.00
2.0
1.7
1290.62
1276.45
nmol/l
0.02
12
157
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
4.0
3.2
4.24
4.45
pmol/l
—
5
46
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
31
310
1.00
-0.00
4.1
3.2
0.00
0.00
estimate
-0.00
15
90
0
8
0.00
-0.00
0.0
6.5
—
—
—
0
0
18
180
1.00
-0.00
2.4
3.3
0.29
1.98
e6/l
1.90
11
89
0
5
0.00
-0.00
0.0
2.8
—
4.69
—
0
5
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.8
—
10.44
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
8
89
0.89
-0.00
2.8
4.1
56.25
164.05
ng/l
—
8
80
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
41.75
—
0
6
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.7
—
69.43
—
0
7
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_SALIVARYNAS – Malignant neoplasm of other and unspecified major salivary glands
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).